Previous studies have demonstrated that abnormal tryptophan (Trp) metabolism promotes tumor progression by suppressing the cytotoxic activities of multiple immune cells, e.g., CD4+ and CD8+ T cells 31. This evidence concerns the gene CD4 and neoplasm.